| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/04/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 4.6k | $19.43 | $89.2k | | 10/04/2023 |
| 10/04/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 888 | $19.91 | $17.7k | | 10/04/2023 |
| 07/03/2023 | Roivant Sciences Ltd. | ROIV | Grant | Common Shares | 1.3k | $0.00 | $0 | | 07/03/2023 |
| 06/15/2023 | Nautilus Biotechnology, Inc. | | Grant | Stock Option (Right to Buy) | 45k | $3.97 | $178.6k | | 06/15/2023 |
| 02/14/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 5.2k | $19.98 | $104.4k | | 02/13/2023 |
| 02/13/2023 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 2.6k | $20.42 | $53.6k | | 02/13/2023 |
| 10/03/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Common Stock | 50k | $0.00 | $0 | | 10/03/2022 |
| 07/20/2022 | Roivant Sciences Ltd. | ROIV | Grant | Stock Option (Right to Buy) | 186.9k | $4.46 | $833.6k | | 07/20/2022 |
| 06/15/2022 | Nautilus Biotechnology, Inc. | | Grant | Stock Option (Right to Buy) | 86.5k | $2.70 | $233.5k | | 06/15/2022 |
| 06/13/2022 | Kinnate Biopharma Inc. | | Grant | Stock Option (right to buy) | 20.2k | $8.38 | $169.7k | | 06/13/2022 |
| 04/04/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 8.1k | $48.75 | $394.6k | | 04/04/2022 |
| 04/04/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1.3k | $49.90 | $65k | | 04/04/2022 |
| 04/04/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 2.8k | $50.70 | $142.9k | | 04/04/2022 |
| 04/04/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 4.5k | $51.99 | $234.6k | | 04/04/2022 |
| 04/04/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 353 | $52.44 | $18.5k | | 04/04/2022 |
| 02/23/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 702 | $49.59 | $34.8k | | 02/23/2022 |
| 02/23/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1.2k | $48.81 | $59.1k | | 02/23/2022 |
| 02/10/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Common Stock | 16.4k | $0.00 | $0 | | 02/10/2022 |
| 02/10/2022 | Zentalis Pharmaceuticals, Inc. | ZNTL | Grant | Stock Option (Right to Buy) | 38.5k | $52.61 | $2M | | 02/10/2022 |
| 10/02/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Payment of Exercise | Common Stock | 17.1k | $67.13 | $1.1M | | 10/02/2021 |
| 07/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 700 | $50.10 | $35.1k | | 07/01/2021 |
| 07/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1.4k | $51.15 | $70.5k | | 07/01/2021 |
| 07/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 805 | $52.01 | $41.9k | | 07/01/2021 |
| 07/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 200 | $53.19 | $10.6k | | 07/01/2021 |
| 06/11/2021 | Kinnate Biopharma Inc. | | Grant | Stock Option (right to buy) | 20.2k | $24.46 | $495.3k | | 06/11/2021 |
| 06/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 200 | $54.90 | $11k | | 06/01/2021 |
| 06/01/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 2.9k | $53.99 | $155.7k | | 06/01/2021 |
| 05/03/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 350 | $56.99 | $19.9k | | 05/03/2021 |
| 05/03/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 661 | $58.04 | $38.4k | | 05/03/2021 |
| 05/03/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 950 | $59.83 | $56.8k | | 05/03/2021 |
| 05/03/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 1.1k | $60.14 | $67.5k | | 05/03/2021 |
| 04/05/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 83 | $45.06 | $3.7k | | 04/05/2021 |
| 04/05/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 3.1k | $43.43 | $133.9k | | 04/05/2021 |
| 04/05/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 13.8k | $43.37 | $598.1k | | 04/05/2021 |
| 04/05/2021 | Zentalis Pharmaceuticals, Inc. | ZNTL | Sale | Common Stock | 149 | $44.21 | $6.6k | | 04/05/2021 |
|